The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations - PubMed

The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations

Fatemeh Delkhosh-Kasmaie et al. Biomed Pharmacother. 2018 Nov.

Abstract

Safranal is one of saffron constituents and has antioxidant and neuroprotective properties. Metformin is used as an anti-diabetic drug. This study was planned to investigate the separate and combined treatment effects of safranal and metformin on diabetes-induced learning and memory impairments by behavioral and hippocampal histopathological and biochemical evaluations. Diabetes was induced by intraperitoneal injection of streptozotocin (STZ), treatments with safranal (0.025, 0.1 and 0.4 mg/kg), metformin (50 and 200 mg/kg), and a combination of low doses of this chemicals were initiated after confirmation of diabetes and continued for 37 days. Blood glucose concentration was measured before and on days 15, 25 and 35 after injection of streptozotocin. Learning and memory tested using Morris Water Maze (MWM) on days 40-45 and on day 45 hippocampal specimens were collected for determination of malodialdehyde (MDA), tumor necrosis factor-alpha (TNF-α) and Caspase-3 levels and superoxide dismutase (SOD) activity. The hippocampus was also designed for light microscopy evaluation. Hyperglycemia, spatial learning and memory impairments, hippocampal neuron loss, increase of hippocampal MDA, TNF-α and caspase-3 levels and decrease of SOD activity were observed in diabetic rats. Safranal (0.1 and 0.4 mg/kg), metformin (200 mg/kg) and safranal (0.025 mg/kg) with metformin (50 mg/kg) improved the above-mentioned behavioral, histopathological and biochemical changes. Safranal and metformin and their combination improved learning and memory impairments in STZ-induced diabetic rats. Antioxidant, anti-inflammatory and antiapoptotic mechanisms might be involved. It is recommended that safranal be considered for diabetes management.

Keywords: Diabetes; Learning and memory impairments; Metformin; Rats; Safranal.

Similar articles

• Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms.

  Baluchnejadmojarad T, Mohamadi-Zarch SM, Roghani M. Baluchnejadmojarad T, et al. Metab Brain Dis. 2019 Dec;34(6):1747-1759. doi: 10.1007/s11011-019-00481-6. Epub 2019 Aug 17. Metab Brain Dis. 2019. PMID: 31422512

• Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.

  Samarghandian S, Borji A, Delkhosh MB, Samini F. Samarghandian S, et al. J Pharm Pharm Sci. 2013;16(2):352-62. doi: 10.18433/j3zs3q. J Pharm Pharm Sci. 2013. PMID: 23958204

• Fish oil improves learning impairments of diabetic rats by blocking PI3K/AKT/nuclear factor-κB-mediated inflammatory pathways.

  Jia D, Heng LJ, Yang RH, Gao GD. Jia D, et al. Neuroscience. 2014 Jan 31;258:228-37. doi: 10.1016/j.neuroscience.2013.11.016. Epub 2013 Nov 16. Neuroscience. 2014. PMID: 24252320

• Neuroprotective Potency of Safranal Against Neurological Disorders.

  Fazeli E, Ghalibaf MHE, Forouzanfar F. Fazeli E, et al. Curr Mol Med. 2023;23(9):952-959. doi: 10.2174/1566524023666221117104612. Curr Mol Med. 2023. PMID: 36397621 Review.

• Mechanism behind the anti-tumour potential of saffron (Crocus sativus L.): The molecular perspective.

  Patel S, Sarwat M, Khan TH. Patel S, et al. Crit Rev Oncol Hematol. 2017 Jul;115:27-35. doi: 10.1016/j.critrevonc.2017.04.010. Epub 2017 Apr 27. Crit Rev Oncol Hematol. 2017. PMID: 28602167 Review.

Cited by

• Neuroprotective Effect of Wharton's Jelly-Derived Mesenchymal Stem Cell-Conditioned Medium (WJMSC-CM) on Diabetes-Associated Cognitive Impairment by Improving Oxidative Stress, Neuroinflammation, and Apoptosis.

  Aghaei Z, Karbalaei N, Namavar MR, Haghani M, Razmkhah M, Ghaffari MK, Nemati M. Aghaei Z, et al. Stem Cells Int. 2023 Apr 11;2023:7852394. doi: 10.1155/2023/7852394. eCollection 2023. Stem Cells Int. 2023. PMID: 37081849 Free PMC article.

• Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms.

  Baluchnejadmojarad T, Mohamadi-Zarch SM, Roghani M. Baluchnejadmojarad T, et al. Metab Brain Dis. 2019 Dec;34(6):1747-1759. doi: 10.1007/s11011-019-00481-6. Epub 2019 Aug 17. Metab Brain Dis. 2019. PMID: 31422512

• Soy isoflavones ameliorate the cognitive dysfunction of Goto-Kakizaki rats by activating the Nrf2-HO-1 signalling pathway.

  Ke B, Zhang T, An T, Lu R. Ke B, et al. Aging (Albany NY). 2020 Nov 7;12(21):21344-21354. doi: 10.18632/aging.103877. Epub 2020 Nov 7. Aging (Albany NY). 2020. PMID: 33180745 Free PMC article.

• The role of Safranal and saffron stigma extracts in oxidative stress, diseases and photoaging: A systematic review.

  Nanda S, Madan K. Nanda S, et al. Heliyon. 2021 Feb 10;7(2):e06117. doi: 10.1016/j.heliyon.2021.e06117. eCollection 2021 Feb. Heliyon. 2021. PMID: 33615006 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program